APG-1387

APG-1387 · Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for APG-1387, covering 2021-08-26 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors [Phase 1, Phase 2]